Accuray Incorporated (0H8I.L)
0H8I.L Stock Price Chart
Explore Accuray Incorporated interactive price chart. Choose custom timeframes to analyze 0H8I.L price movements and trends.
0H8I.L Company Profile
Discover essential business fundamentals and corporate details for Accuray Incorporated (0H8I.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
29 Jan 2018
Employees
987.00
Website
https://www.accuray.comCEO
Suzanne Winter
Description
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.
0H8I.L Financial Timeline
Browse a chronological timeline of Accuray Incorporated corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 3 Feb 2026
Upcoming earnings on 5 Nov 2025
Revenue estimate is $92.22M.
Earnings released on 13 Aug 2025
EPS came in at $0.01 falling short of the estimated $0.01 by -22.66%, while revenue for the quarter reached $127.54M , beating expectations by +37.22%.
Earnings released on 30 Apr 2025
EPS came in at -$0.01 surpassing the estimated -$0.05 by +81.25%, while revenue for the quarter reached $113.24M , missing expectations by -8.51%.
Earnings released on 5 Feb 2025
EPS came in at $0.02 surpassing the estimated -$0.03 by +189.66%, while revenue for the quarter reached $116.17M , beating expectations by +5.27%.
Earnings released on 7 Nov 2024
EPS came in at -$0.04 surpassing the estimated -$0.05 by +20.00%, while revenue for the quarter reached $101.55M , beating expectations by +4.10%.
Earnings released on 15 Aug 2024
EPS came in at $0.03 surpassing the estimated $0.03 by +11.77%, while revenue for the quarter reached $134.29M , beating expectations by +10.52%.
Earnings released on 2 May 2024
EPS came in at -$0.06 falling short of the estimated -$0.02 by -283.50%, while revenue for the quarter reached $101.13M , missing expectations by -12.79%.
Earnings released on 12 Mar 2024
EPS came in at -$0.10 falling short of the estimated -$0.04 by -136.82%, while revenue for the quarter reached $107.24M , beating expectations by +0.53%.
Earnings released on 8 Nov 2023
EPS came in at -$0.03 surpassing the estimated -$0.05 by +38.50%, while revenue for the quarter reached $103.89M , beating expectations by +6.42%.
Earnings released on 10 Aug 2023
EPS came in at -$0.03 falling short of the estimated $0.01 by -366.40%, while revenue for the quarter reached $118.29M , missing expectations by -2.84%.
Earnings released on 27 Apr 2023
EPS came in at $0.01 surpassing the estimated -$0.01 by +152.70%, while revenue for the quarter reached $118.06M , beating expectations by +7.55%.
Earnings released on 2 Feb 2023
EPS came in at -$0.02 surpassing the estimated -$0.03 by +25.07%, while revenue for the quarter reached $114.76M , beating expectations by +7.22%.
Earnings released on 30 Sept 2022
EPS came in at -$0.06 falling short of the estimated -$0.03 by -90.21%, while revenue for the quarter reached $96.49M , missing expectations by -3.45%.
Earnings released on 30 Jun 2022
EPS came in at -$0.04 surpassing the estimated -$0.06 by +38.17%, while revenue for the quarter reached $110.02M , beating expectations by +4.47%.
Earnings released on 31 Mar 2022
EPS came in at -$0.01 surpassing the estimated -$0.06 by +80.38%, while revenue for the quarter reached $96.17M , beating expectations by +0.13%.
Earnings released on 31 Dec 2021
EPS came in at $0.00 , while revenue for the quarter reached $116.28M .
Earnings released on 30 Sept 2021
EPS came in at -$0.01 falling short of the estimated $0.00 by -383.00%, while revenue for the quarter reached $107.44M , beating expectations by +3.99%.
Earnings released on 30 Jun 2021
EPS came in at -$0.12 , while revenue for the quarter reached $110.94M .
Earnings released on 31 Mar 2021
EPS came in at -$0.00 , while revenue for the quarter reached $102.56M .
Earnings released on 31 Dec 2020
EPS came in at $0.05 , while revenue for the quarter reached $97.46M .
Earnings released on 30 Sept 2020
EPS came in at $0.00 , while revenue for the quarter reached $85.33M .
0H8I.L Stock Performance
Access detailed 0H8I.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.